Developer docs
API playgroundTry for free, no card

Search company profiles

Histalim

Full company profile

uuid002zurq

Namestring
Histalim
Websiteurl
histalim.com
Company typeenum
Private
Founded yearint
2005
Short descriptiontext

Histalim is a domain-linked entity (histalim.com) with no verifiable business activity documented in available sources — the domain resolves only to a Plesk default hosting placeholder and no products, customers, leadership, or operating footprint have been disclosed.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Industry1 code
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
Product category
Unknown
Social media profiles1 record
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No substantive information about Histalim's core offerings is available. The company website (histalim.com) displays only a default Plesk web hosting placeholder page with no descriptions of products, services, or business activities.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

International bioanalytical and preclinical testing group with histology and pathology service offerings through its pharma services segment. Comparable as a broad incumbent providing adjacent lab services to pharma/biotech.

TypeDirect peer
Description

Specialty histopathology and digital pathology services provider for academic and biopharma clients. Directly comparable if Histalim operates as a histopathology services lab, given the identical core offering of tissue processing, staining, and slide digitization.

TypeDirect peer
Description

Specialty provider of immunohistochemistry, histology, and tissue services to research customers. Comparable as a direct peer if Histalim operates in research-grade histopathology services.

TypeDirect peer
Description

Preclinical contract research organization with histology, pathology, and toxicology services for medical device and pharma clients. Comparable as a direct peer offering tissue-based preclinical services.

TypeBroad incumbent
Description

Preclinical CRO focused on oncology and immuno-oncology models, with histology and biomarker services supporting translational research. Comparable as an incumbent serving similar pharma/biotech research customers.

TypeBroad incumbent
Description

Large CRO with a broad preclinical services portfolio that includes histology, pathology, and toxicology. Relevant as a broad incumbent competitor that offers overlapping histopathology capability to pharma clients.

TypeBroad incumbent
Description

Global CRO/CDMO with preclinical histology, pathology, and DMPK service lines. Comparable as a broad incumbent offering overlapping preclinical lab services to biopharma.

TypeBroad incumbent
Description

Global preclinical and clinical CRO with significant histopathology, toxicology, and DMPK service lines. Comparable as a large incumbent that competes for outsourced preclinical histology work.

TypeDirect peer
Description

Preclinical CRO offering histology and pathology evaluation alongside toxicology studies. Comparable as a direct peer offering histology services embedded in preclinical study packages.

TypeRegional player
Description

Europe-headquartered preclinical and clinical lab services provider with histopathology capability. Comparable as a regional peer serving European biopharma clients in similar histology services.

Market position
Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Histalim

Histalim is a domain-linked entity (histalim.com) with no verifiable business activity documented in available sources — the domain resolves only to a Plesk default hosting placeholder and no products, customers, leadership, or operating footprint have been disclosed.

Histalim firmographics

Firmographics
Name
Histalim
Website
https://histalim.com
Company type
Private
Founded year
2005
Headcount range
11–50 employees
Short description
Histalim is a domain-linked entity (histalim.com) with no verifiable business activity documented in available sources — the domain resolves only to a Plesk default hosting placeholder and no products, customers, leadership, or operating footprint have been disclosed.
Ownership category
akta.pro rank

Histalim industry classification

Industry
Product category
Unknown
akta.pro industry
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Where Histalim is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Markets served

Histalim business model

Business model
GTM type
B2B
Offering type
Services

Histalim product offering

Product offering

Core offering

No substantive information about Histalim's core offerings is available. The company website (histalim.com) displays only a default Plesk web hosting placeholder page with no descriptions of products, services, or business activities.

Differentiator

Problem solved

Functional benefit

Histalim technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Histalim competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: International bioanalytical and preclinical testing group with histology and pathology service offerings through its pharma services segment. Comparable as a broad incumbent providing adjacent lab services to pharma/biotech.
  • Crown Bioscience: Preclinical CRO focused on oncology and immuno-oncology models, with histology and biomarker services supporting translational research. Comparable as an incumbent serving similar pharma/biotech research customers.
  • Charles River Laboratories: Large CRO with a broad preclinical services portfolio that includes histology, pathology, and toxicology. Relevant as a broad incumbent competitor that offers overlapping histopathology capability to pharma clients.
  • Pharmaron: Global CRO/CDMO with preclinical histology, pathology, and DMPK service lines. Comparable as a broad incumbent offering overlapping preclinical lab services to biopharma.
  • WuXi AppTec: Global preclinical and clinical CRO with significant histopathology, toxicology, and DMPK service lines. Comparable as a large incumbent that competes for outsourced preclinical histology work.

Direct peers

  • HistoWiz: Specialty histopathology and digital pathology services provider for academic and biopharma clients. Directly comparable if Histalim operates as a histopathology services lab, given the identical core offering of tissue processing, staining, and slide digitization.
  • IHC World: Specialty provider of immunohistochemistry, histology, and tissue services to research customers. Comparable as a direct peer if Histalim operates in research-grade histopathology services.
  • Toxikon: Preclinical contract research organization with histology, pathology, and toxicology services for medical device and pharma clients. Comparable as a direct peer offering tissue-based preclinical services.
  • Comparative Biosciences: Preclinical CRO offering histology and pathology evaluation alongside toxicology studies. Comparable as a direct peer offering histology services embedded in preclinical study packages.

Regional players

  • Cerba Research: Europe-headquartered preclinical and clinical lab services provider with histopathology capability. Comparable as a regional peer serving European biopharma clients in similar histology services.

Market position

Customer concentration

Histalim social profiles

Digital presence

Histalim financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Histalim leadership team

Management profile

Number of profiles

Histalim funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Histalim M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Histalim

What does Histalim do?

No substantive information about Histalim's core offerings is available. The company website (histalim.com) displays only a default Plesk web hosting placeholder page with no descriptions of products, services, or business activities.

When was Histalim founded?

Histalim was founded in 2005. It employs 11 to 50 people.

Where is Histalim based?

Histalim is headquartered in Montpellier, France, in the Europe region.

Who are Histalim's main competitors?

Broad incumbents on record are Eurofins Scientific, Crown Bioscience, Charles River Laboratories, Pharmaron and WuXi AppTec. Direct peers are HistoWiz, IHC World, Toxikon and Comparative Biosciences. Cerba Research is listed as a regional player.

Does Histalim have an API?

No public API is recorded for Histalim.

What industry is Histalim in?

Histalim's product category is Unknown. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales